(NaturalNews) A recent clinical trial was jointly conducted by the UCLA Mary S. Easton Center for Alzheimer's Disease Research, located in Los Angeles, CA, and the Buck Institute for Research on Aging in Novato, CA, 30 miles north of San Francisco. Those two combined resources to try a new approach for Alzheimer's patients that combined several protocols according to individual needs.

Their purpose was to prove that dietary and lifestyle changes could reverse or reduce memory and cognitive dysfunction, even Alzheimer's, with minimal pharmaceutical intervention. The researchers tried bundles of mostly dietary changes, supplements and exercise routines on 10 trial participants who were suffering with various stages of Alzheimer's disease (AD) and other symptoms of dementia.

Since first being identified some 100 years ago, cases of Alzheimer's have risen exponentially to become the sixth leading cause of death. At least that's according to the CDC. But one wonders if there is a blurred distinction between cause of death from Alzheimer's or simply death with Alzheimer's, as pneumonia is usually involved.

Even if one physically survives long after Alzheimer's has become so advanced that one no longer knows one's family or has any memory of his or her personal history or can barely function and often functions inappropriately, that person has become a total invalid. The prevailing actual medical causes of Alzheimer's patients is pneumonia.

After 100 years, mainstream medicine has no safe pharmaceutical solutions for Alzheimer's victims, who number over 5 million in the USA. The FDA has approved five drugs for treating Alzheimer's, but not one drug has been successful at even slowing AD's progress. The usual therapeutic approach for Alzheimer's has been combining several drugs simultaneously, which creates a cascade of side effects without curing the AD.

The trial used a flexible 36-point therapeutic systemThe trial's report was published in the online journal Aging. Dale Bredesen, professor of neurology and director of the Easton Center at UCLA, developed the 36-point therapy that was tested in this clinical trial.

He explained how each patient needed to have the program suited to his or her special needs, general health and physiology. But usually the maximum pharmaceutical use was one drug only that could be reduced to none as long as the FDA, AMA and Big Pharma aren't looking. Perhaps that minimal drug use was to stay within "standard of care" guidelines and avoid the wrath of the AMA.

The results were more favorable than any pharmaceutical trial study, and no one died. Only one patient didn't improve. That was a person with advanced Alzheimer's. A few who were no longer able to work returned to work fully functional.

The problem with this approach within the medical monopoly prescription-writing one-size-fits-all mindset is the fact that it's complex and needs to be personalized and monitored closely. Dr. Bredesen can't clone himself.

Here are two simple DIY solutions: coconut oil and cannabisCoconut oil is legal everywhere, and it's cheap. Coconut oil's efficacy for even advanced Alzheimer's was discovered by Dr. Mary Newport when she missed out on getting her husband into the latest drug trial for Alzheimer's drugs.

Mary realized that the crux of the new synthetic drug dealt with medium chain triglycerides (MCTs). MCTs are easily converted by the liver into ketones, which can be used by a brain struggling with oxygen for energy.

She discovered that coconut oil contained high amounts of MCTs and began feeding her husband 2 to 4 tablespoons daily. His late-stage Alzheimer's soon improved considerably.Here's more.

If you can get it, cannabis has demonstrated both empirical and medical proof of its efficacy for Alzheimer's disease. Why bother with studies and waiting for dangerous drugs if people are curing themselves of memory loss, cognitive disorders and even Alzheimer's safely? Here's more on this.